The change in epigenetics is observed widely with the origin of functions of the genome which damages the activity of genes and its factors, deprived of the DNA variations in the sequence affecting the person includes neurodevelopmental syndromes like migraine, epilepsy, schizophrenia and autism (L & F, 2008).
Epigenetic variations are important as they have been associated with the variety of syndromes in the nervous system. For treating these syndrome and maintaining the neoplasm and nervous functionality, the important factors and fundamental techniques intricated in epigenetic that could prime this treatments of nervous and psychiatric issues. This can have enduring effects on the functionality of genome controlling. It may have diverse effects including schizophrenia, shock, burning, sensitivity and pain disorders also including the factors affecting the molecular disorders involving several genes factors (K et al. 2011).
There is a need to develop an environment that will help in growth of cells by the functions of epigenetic as these functionalities are important for the normal growth and development of the genetic tissues in the body for neuronal development. (Y et al. 2008)
Interruption of epigenetic developments can damage the functionality of genes and malicious for the development of cells and damages the neural activity. There is a need to develop the epigenetics instruments and innovatory devices to develop the nervous functionality, including the DNA methylation, alterations of histone and RNAs for the elimination of these neural epigenetically issues. These strategies will work best for the characterization of the nervous and neoplasm functionality with the help of pathways of pathogenic, screening, analyzation, intensive care, and treatment (RG, JV, & MD, 2009).
Kikuchi K, Miura N, Morimoto Y, Ito T, Tancharoen S, et al. (2011) Beneficial Effects of the Free RadicalScavenger Edaravone (Radicut) in Neurologic Diseases. J Neurol Neurophysiol S1-001.
Migliore L, Coppedè F (2008) Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 674:73-84.
Jiang Y, Langley B, Lubin FD, Renthal W, Wood MA, et al. (2008) Epigenetics in the Nervous System. The Journal of Neuroscience 28: 11753-11759.
Urdinguio RG, Sanchez-Mut JV, Manel Esteller MD (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. The Lancet Neurology 8: 1056-1072.